Rising Cancer Burden Accelerates the U.S. Oncology Based Molecular Diagnostics Market
The U.S. Oncology Based Molecular Diagnostics Market is witnessing remarkable growth as precision medicine continues to redefine cancer diagnosis, treatment planning, and patient outcomes. Advances in genomic technologies, increasing adoption of biomarker testing, and the growing prevalence of cancer are accelerating demand for sophisticated molecular diagnostic solutions across the United...
0 Comentários 0 Compartilhamentos 188 Visualizações 0 Anterior